Technical Analysis for ALNA - Allena Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 6.54 2.99% 0.19
ALNA closed up 2.99 percent on Tuesday, April 23, 2019, on 30 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical ALNA trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Touch Weakness 2.99%
NR7 Range Contraction -0.91%
Slingshot Bearish Bearish Swing Setup -2.10%
Bullish Engulfing Bullish -2.10%
Stochastic Buy Signal Bullish -2.10%
Lower Bollinger Band Touch Weakness -2.10%
Oversold Stochastic Weakness -2.10%
Volume Surge Other 7.39%
Lower Bollinger Band Walk Weakness 7.39%
Below Lower BB Weakness 7.39%

Older signals for ALNA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Allena Pharmaceuticals, Inc. is a United States-based specialty biopharmaceutical company. The Company is focused on developing and commercializing non-systemic oral protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions. Its lead product candidate, ALLN-177, is in an ongoing Phase II clinical trial and is being developed for the chronic management of hyperoxaluria and kidney stones. ALLN-177 is an orally administered, recombinant oxalate-degrading enzyme. ALLN-177 targets oxalate in the gastrointestinal (GI) tract to reduce the burden of both dietary and endogenously produced oxalate. ALLN-177 has the potential to decrease the oxalate available systemically for deposition as calcium oxalate crystals or stones in the kidneys, as well as to reduce the incidence of calcium oxalate related complications. Its technological approach enables the design and development of oral protein therapies that remain in the GI tract.
Medicine Biopharmaceutical Medical Specialties Organ Systems Kidney Diseases Anticoagulants Hyperoxaluria
Is ALNA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 17.26
52 Week Low 4.8
Average Volume 41,020
200-Day Moving Average 8.7135
50-Day Moving Average 6.7974
20-Day Moving Average 6.658
10-Day Moving Average 6.436
Average True Range 0.3757
ADX 19.12
+DI 15.7678
-DI 28.4223
Chandelier Exit (Long, 3 ATRs ) 6.1829
Chandelier Exit (Short, 3 ATRs ) 6.9371
Upper Bollinger Band 7.2162
Lower Bollinger Band 6.0998
Percent B (%b) 0.39
BandWidth 16.767798
MACD Line -0.1525
MACD Signal Line -0.1428
MACD Histogram -0.0097
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.15
Resistance 3 (R3) 7.08 6.81 7.05
Resistance 2 (R2) 6.81 6.66 6.84 7.01
Resistance 1 (R1) 6.68 6.56 6.74 6.74 6.98
Pivot Point 6.41 6.41 6.44 6.44 6.41
Support 1 (S1) 6.27 6.25 6.34 6.34 6.10
Support 2 (S2) 6.00 6.15 6.03 6.07
Support 3 (S3) 5.87 6.00 6.03
Support 4 (S4) 5.93